Aspirin May Reduce Ovarian Cancer Risk

Published Online: Wednesday, June 11, 2014
Women who take aspirin regularly may be at a reduced risk for ovarian cancer, the results of a meta-analysis suggest. The study, published online on February 6, 2014, in the Journal of the National Cancer Institute, analyzed data from population-based studies to help determine the association between the use of aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, and acetaminophen and the risk of developing ovarian cancer. The results indicated that regular aspirin use was associated with a reduced risk of ovarian cancer. Among 7 studies that reported frequency of use, daily use of aspirin was associated with a 20% decrease in ovarian cancer risk. In 3 studies that included dose information, low-dose aspirin use (less than 100 mg per day) was associated with a 34% reduction in ovarian cancer risk.

Latest Articles
This weekly video program highlights the latest in pharmacy news, product news, and more.
Propranolol is red, digoxin is blue. Your pharmacist’s heart may skip a beat if they get a valentine from you.
Health-system pharmacists can play a critical role in managing drug shortages to prevent medical errors and adverse events.
The White House is asking Congress for more than $1.8 billion in emergency funding to combat the Zika virus, which is creeping into the United States and ravaging some foreign countries.
Latest Issues
$auto_registration$